SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.
Phone: 02 9698 2022
Selleck Chemicals FDA-approved Anticancer Drug Library
Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential...
Cytek Tonbo Mouse TBNK/Myeloid/Treg Kit
The kit has been designed to enable researchers to quickly perform basic immunophenotyping and...
FUJIFILM Irvine Scientific Shenandoah Cytokines
FUJIFILM Irvine Scientific provides recombinant cytokines to the academic and industrial...
